212 related articles for article (PubMed ID: 29479832)
1. Osteoporosis in chronic liver disease.
Guañabens N; Parés A
Liver Int; 2018 May; 38(5):776-785. PubMed ID: 29479832
[TBL] [Abstract][Full Text] [Related]
2. Liver and bone.
Guañabens N; Parés A
Arch Biochem Biophys; 2010 Nov; 503(1):84-94. PubMed ID: 20537977
[TBL] [Abstract][Full Text] [Related]
3. Bone Health in Patients With Liver Diseases.
Danford CJ; Trivedi HD; Bonder A
J Clin Densitom; 2020; 23(2):212-222. PubMed ID: 30744928
[TBL] [Abstract][Full Text] [Related]
4. Management of osteoporosis in liver disease.
Guañabens N; Parés A
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):438-45. PubMed ID: 21546334
[TBL] [Abstract][Full Text] [Related]
5. Bone disorders in cholestatic liver diseases.
Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F
Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in chronic liver disease.
Yadav A; Carey EJ
Nutr Clin Pract; 2013 Feb; 28(1):52-64. PubMed ID: 23263929
[TBL] [Abstract][Full Text] [Related]
7. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
[TBL] [Abstract][Full Text] [Related]
8. Cholestasis and metabolic bone disease - a clinical review.
Gasser RW
Wien Med Wochenschr; 2008; 158(19-20):553-7. PubMed ID: 18998071
[TBL] [Abstract][Full Text] [Related]
9. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders.
Pietrzyk B; Smertka M; Chudek J
Adv Clin Exp Med; 2017 Nov; 26(8):1283-1291. PubMed ID: 29264888
[TBL] [Abstract][Full Text] [Related]
11. [Osteoporosis in liver cirrhosis].
Guañabens N; Parés A
Gastroenterol Hepatol; 2012; 35(6):411-20. PubMed ID: 22483016
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
[TBL] [Abstract][Full Text] [Related]
13. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.
Diamond TH; Stiel D; Lunzer M; McDowall D; Eckstein RP; Posen S
Gastroenterology; 1989 Jan; 96(1):213-21. PubMed ID: 2783312
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
15. Bone disorders in chronic liver disease.
Collier J
Hepatology; 2007 Oct; 46(4):1271-8. PubMed ID: 17886334
[TBL] [Abstract][Full Text] [Related]
16. Hepatic osteodystrophy.
Goel V; Kar P
Trop Gastroenterol; 2010; 31(2):82-6. PubMed ID: 20862980
[TBL] [Abstract][Full Text] [Related]
17. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry.
Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
Hepatology; 2002 Oct; 36(4 Pt 1):895-903. PubMed ID: 12297836
[TBL] [Abstract][Full Text] [Related]
18. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
19. Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis.
Parés A; Guañabens N; Rodés J
Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):311-5. PubMed ID: 15716655
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Osteodystrophy: A Global (Re)View of the Problem.
Barbu EC; Chițu-Tișu CE; Lazăr M; Olariu C; Bojincă M; Ionescu RA; Ion DA; Bădărău IA
Acta Clin Croat; 2017 Sep; 56(3):512-525. PubMed ID: 29479918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
